Product Images Doxazosin Mesylate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Doxazosin Mesylate NDC 10544-292 by Blenheim Pharmacal, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Graphic- 1mg 90s - Label Graphic 1mg 90s

Label Graphic- 1mg 90s - Label Graphic  1mg 90s

This is a prescription drug called Doxazosin Mesylate available in tablet form with a strength of 1mg. The drug comes in a pack of 90 tablets. The package insert should be followed for the dosage. It should be stored at a controlled room temperature and kept out of the reach of children. The lot number and expiration date are also provided in the text.*

Label Graphic- 4mg 90s - Label Graphic 4mg 90s

Label Graphic- 4mg 90s - Label Graphic  4mg 90s

This text is a medication label for Doxazosin Mesylate Tablets at a dosage of 4mg, with 90 tablets per bottle. It includes information on storage recommendations, dosage, and precautions for children. There are also several NDC and MFG numbers, lot numbers, and expiration dates listed.*

DOXAZOSIN MESYLATE Molecular Structure - image 01

DOXAZOSIN MESYLATE Molecular Structure - image 01

TABLE 1. SUMMARY OF EFFECTIVENESS DATA IN PLACEBO-CONTROLLED TRIALS - image 02

TABLE 1. SUMMARY OF EFFECTIVENESS DATA IN PLACEBO-CONTROLLED TRIALS - image 02

This is a table showing effectiveness data in placebo-controlled trials for the treatment of BPH using doxazosin mesylate at various doses. The data includes changes in symptom score and maximum flow rate. Study 1 evaluated the maximum dose of 4mg, study 2 evaluated a fixed dose for 14 weeks, and study 3 evaluated a fixed dose for 12 weeks. The effectiveness was measured using AUA and Modified Boyarsky Questionnaires. The table also indicates that the study was conducted on hypertensive patients with BPH.*

Graph: Mean Change in Total Symptom Score from Baseline - image 03

Graph: Mean Change in Total Symptom Score from Baseline - image 03

The text describes a figure called Figure 1, which displays the mean change in total symptom score from baseline. The X-axis represents the duration of treatment in weeks, and the Y-axis represents the mean change in symptom score. There are data points at weeks 2, 4, 6, 8, 10, 12, and 14.*

Graph: Mean Increase in Maximum Urinary Flow Rate (mL/sec) from Baseline - image 04

Graph: Mean Increase in Maximum Urinary Flow Rate (mL/sec) from Baseline - image 04

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.